1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Temporal Improvements in Survival and Independent Prognostic Factors in Multiple Myeloma: A Large Population-Based Cohort Study

MM - 1234

Temporal Improvements in Survival and Independent Prognostic Factors in Multiple Myeloma: A Large Population-Based Cohort Study

Sumeet Kumar

Poster Presenter: Sumeet Kumar

$Thumbnail for Temporal Patterns of Efficacy and Toxicity of CD20ΧCD3 Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review$

ABCL - 201

Temporal Patterns of Efficacy and Toxicity of CD20ΧCD3 Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review

Mehak Khetarpal

Poster Presenter: Mehak Khetarpal

SOHO 2026 Annual Meeting

Posters by Title

Temporal Improvements in Survival and Independent Prognostic Factors in Multiple Myeloma: A Large Population-Based Cohort Study

Temporal Patterns of Efficacy and Toxicity of CD20ΧCD3 Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review

Temporal Patterns of Infectious Complications Following BCMA-Directed CAR-T Therapy in Multiple Myeloma: A Propensity-Matched Real-World Analysis

Temporal Trends and Demographic Disparities in Hematologic Malignancy Mortality in the United States

Temporal Trends and Demographic Disparities in Mortality From Multiple Myeloma and Leukemia With Coexisting Coagulation and Hemorrhagic Disorders in the United States, 1999-2024: A CDC WONDER Multiple-Cause Mortality Analysis

Temporal Trends and Demographic Disparities in Non-ALL Lymphoid Leukemia Mortality in the United States, 1999-2025: A CDC WONDER Analysis

Temporal Trends and Disparities in Place of Death Among Patients With Lymphoma in the United States: A Nationwide CDC WONDER Analysis, 1999-2020

Temporal Trends and Pandemic Disruption in Co-Contributing Mortality From Multiple Myeloma and Chronic Ischemic Heart Disease in Older Adults (1999-2024)

Temporal Trends in Cardiovascular Toxicity with Second-Generation BTK Inhibitors: Acalabrutinib versus Zanubrutinib